Skip to main content
. 2020 Nov 6;29:115860. doi: 10.1016/j.bmc.2020.115860

Table 3.

Reported SARS-CoV-2 Mpro inhibitors and biological properties.

Entry Name SARS-CoV-2 Mpro IC50 (µM) pIC50
1 N3
2 Ebselen 0.67 6.174
3 Disulfiram 9.35 5.029
4 Tideglusib 1.55 5.810
5 Carmofur 1.82 5.740
6 Shikonin 15.75 4.803
7 PX-12 21.39 4.670
8 Cinanserin 124.93 3.903
9 11a 0.053 7.276
10 11b 0.04 7.398
11 11r 0.18 6.745
12 13a 2.39 5.622
13 13b 0.67 6.174
14 14b
15 Simeprevir 13.74 4.862
16 Boceprevir 4.13 5.384
17 Narlaprevir 5.73 5.242
18 MG-132 3.9 5.409
19 Calpeptin 10.69 4.971
20 Calpain inhibitor III >20
21 Calpain inhibitor VI >20
22 Calpain inhibitor I (ALLN) 8.6 5.066
23 MG-115 3.14 5.503
24 Calpain inhibitor II (ALLM) 0.97 6.013
25 Calpain inhibitor XII 0.45 6.347
26 PSI 10.38 4.984
27 GC-376 0.03 7.523
28 Rupintrivir >20
29 Camostat >20
30 Lopinavir >20
31 Ritonavir >20
32 Baicalin 6.41 5.193
33 Baicalein 0.94 6.027